Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial cell growth

European Journal of Pharmacology

Volumn 361, Issue 2-3, 1998, Pages 285-291

  Inoue, Tomoo ^a   Mi, Zaichuan ^a   Gillespie, Delbert G ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

3H Thymidine incorporation; Cyclooxygenase inhibition; Mesangial cell; Neuroendocrine vasoconstrictor; NSAID (nonsteroidal anti inflammatory drug)

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; ENDOTHELIN 1; INDOMETACIN; NORADRENALIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; IN VITRO STUDY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIN-1; GLOMERULAR MESANGIUM; INDOMETHACIN; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 0032553624     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00720-1     Document Type: Article

References (29)

1. Arroyo V., Ginés P., Rimola A., Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am. J. Med. 81:1986;104-122. (suppl 2B).
2. Asbert M., Ginès A., Ginès P., Jiménez W., Clària J., Saló J., Arroyo V., Rivera F., Rodés J. Circulating levels of endothelin in cirrhosis. Gastroenterology. 104:1993;1485-1491.
3. Axelsen R.A., Crawford D.H.G., Endre Z.H., Lynch S.V., Balderson G.A., Strong R.W., Fleming S.J. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotropic liver transplantation. Pathology. 27:1995;237-246.
4. Bakris G.L., Fairbanks R., Traish A.M. Arginine vasopressin stimulates human mesangial cell production of endothelin. J. Clin. Invest. 87:1991;1158-1164.
5. 2. J. Clin. Invest. 82:1988;168-176.
6. Cannon P.J. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs. Am. J. Med. 81:1986;123-132. (suppl 2B).
7. Coyne D.W., Nickols M., Bertrand W., Morrison A.R. Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids. Am. J. Physiol. 263:1992;F97-F102.
8. El Nahas A.M. Renal scarring: the role of angiotensin II. Nephrol. Dial. Transplant. 10:1995;28-32. (Suppl 9).
9. Essig M., Dussaule J.-C., Vandermeersch S., Chatziantoniou C., Ardaillou R. Modulation by angiotensin II of endothelial cell control of DNA synthesis in human mesangial cells. Nephron. 75:1997;303-309.
10. Fukuda Y. Renal glomerular changes associated with liver cirrhosis. Acta Pathol. Jpn. 32:1982;561-574.
11. 2 production in an extracellular calcium-independent manner in cultured rat mesangial cells. Am. J. Hypertens. 4:1991;137-143.
12. 2+. Am. J. Physiol. 259:1990;F269-F278.
13. Hughes A.K., Padilla E., Kutchera W.A., Michael J.R., Kohan D.E. Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells. Kidney Int. 47:1995;53-61.
14. Kreisberg J.I., Karnovsky M.J. Glomerular cells in culture. Kidney Int. 23:1983;439-447.
15. Marsen T.A., Schramek H., Dunn M.J. Renal actions of endothelin: linking cellular signaling pathways to kidney disease. Kidney Int. 45:1994;336-344.
16. Matsumura Y., Ozawa Y., Suzuki H., Saruta T. Synergistic action of angiotensin II on norepinephrine-induced prostaglandin release from rat glomeruli. Am. J. Physiol. 250:1986;F811-F816.
17. Menè P., Dunn M.J. Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int. 37:1990;1256-1262.
18. 2 and prostacyclin. Kidney Int. 38:1990;232-239.
19. Montoliu J., Darnell A., Torras A., Revert L. Glomerular disease in cirrhosis of the liver: low frequency of IgA deposits. Am. J. Nephrol. 6:1986;199-205.
20. Nakahama K., Morita I., Murota S. Effects of endogenously produced arachidonic acid metabolites on rat mesangial cell proliferation. Prostaglandins Leukotrienes Essent. Fatty Acids. 51:1994;177-182.
21. Parmley W.W. Neuroendocrine changes in heart failure and their clinical relevance. Clin. Cardiol. 18:1995;440-445.
22. Scharschmidt L.A., Dunn M.J. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. J. Clin. Invest. 71:1983;1756-1764.
23. Seino Y., Ohki K., Nakamura T., Tsukamoto H., Takano T., Aramaki T., Okumura H., Hayakawa H. Pathophysiological characteristics of cutaneous microcirculation in patients with liver cirrhosis: relationships to cardiovascular hemodynamics and plasma neurohormonal factors. Microvasc. Res. 46:1993;206-215.
24. Sellmayer A., Uedelhoven W.M., Weber P.C., Bonventre J.V. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J. Biol. Chem. 266:1991;3800-3807.
25. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J. Clin. Invest. 83:1989;708-712.
26. Tsai Y.-T., Lin H.-C., Yang M.C.-M., Lee F.-Y., Hou M.-C., Chen L.-S., Lee S.-D. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. J. Hepatol. 23:1995;681-688.
27. Wolf G., Haberstroh U., Neilson E.G. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am. J. Pathol. 140:1992;95-107.
28. Zipser R.D. Role of renal prostaglandins and the effects of nonsteroidal anti-inflammatory drugs in patients with liver disease. Am. J. Med. 81:1986;95-103. (suppl 2B).
29. Zuckerman A.L., Stenzel K.H., Suthanthiran M., Holthofer H., Schlondorff D. Modulation of mouse mesangial cell proliferation by thiourea and lipoxygenase inhibitors. Nephron. 66:1994;337-343.